A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Clinical trial NCT07720193 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07720193
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-22
- Primary completion
- 2030-12-22
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.